Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-18-006456
Filing Date
2018-05-10
Accepted
2018-05-10 08:30:14
Documents
69
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rdus0331201810-q.htm 10-Q 920044
2 EXHIBIT 10.1 rdus03311810qex10d1.htm EX-10.1 509616
3 EXHIBIT 10.2 rdus03311810qex10d2.htm EX-10.2 39577
4 EXHIBIT 31.1 rdus03311810qex31d1.htm EX-31.1 11920
5 EXHIBIT 31.2 rdus03311810qex31d2.htm EX-31.2 11817
6 EXHIBIT 32.1 rdus03311810qex32d1.htm EX-32.1 12881
  Complete submission text file 0001628280-18-006456.txt   5644806

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rdus-20180331.xml EX-101.INS 1051995
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rdus-20180331.xsd EX-101.SCH 42038
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rdus-20180331_cal.xml EX-101.CAL 68982
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rdus-20180331_def.xml EX-101.DEF 196911
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rdus-20180331_lab.xml EX-101.LAB 534125
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rdus-20180331_pre.xml EX-101.PRE 317615
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451
Business Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35726 | Film No.: 18820639
SIC: 2834 Pharmaceutical Preparations